Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

The Use of Intravenous Thrombolytics in Acute Ischemic Stroke Patients with Unruptured Intracranial Aneurysm: A Systematic Review and Meta Analysis

Author:Manea, Hashim Talib Hashim   Abdulkareem, Salih   Ali, Zahraa Hussein   Al-Ghuraibawi, Mohammedbaqer A.   Almufadhal, Muntadher H.   

Session Name:P9: General Neurology: Seizures and Assorted Other Neurologic Conditions  

Topic:General Neurology  

Program Number:P9.011  

Author Institution:University of Warith Al-Anbiyaa, College of Medicine , Karbala, Iraq  University of Baghdad, College of Medicine , Baghdad, Iraq  

The 201 Trial in Untreated Parkinson's Disease

Author:Werner, Milton   Olanow, C Warren   McGarry, Andrew   Meyer, Christopher   Mancino, Emaryn   Klint, Carl   Pellecchia, Jacqueline   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.011  

Author Institution:Inhibikase Therapeutics, Inc., Atlanta, GA  Clintrex Research Corporation, Sarasota, FL  Inhibikase Therapeutics, inc., Atlanta, FL  

Adolescent with Unusual Initial Presentation of MOGAD

Author:Johnson, Emma   Marinova Doynova, Antoniya   Moreo, Natalie   Nallu, Sagarika   

Session Name:P9: Autoimmune Neurology: MOGAD  

Topic:Autoimmune Neurology  

Program Number:P9.011  

Author Institution:USF MCOM, Tampa, FL  University of South Florida, Temple Terrace, FL  University of South Florida, Lutz, FL  University of South Florida, Tampa, FL  

Immunoglobulin Level Changes in Patients with Multiple Sclerosis Treated with Anti-CD20 Monoclonal Antibodies

Author:Vollmer, Brandi   Bourassa, Timber   Marsh, Erin   Dao, Vi   Gadkari, Abhijit   Brown, Brandon   Sillau, Stefan   Nair, Kavita   Alvarez, Enrique   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.011  

Author Institution:University of Colorado, Aurora, CO  Novartis, East Hanover, NJ  

Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease

Author:Willis, Brian   Hussein, Ziad   Hayato, Seiichi   Takenaka, Osamu   Penner, Natasha   Yasuda, Sanae   Reyderman, Larisa   

Session Name:P9: Dementia and Behavioral Neurology: Treatments 1  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:P9.011  

Author Institution:Eisai Inc., Nutley, NJ  Eisai Co., Ltd, Hatfield, United Kingdom  Eisai Ltd, Tokyo, Japan